Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
12.77
-0.78 (-5.76%)
At close: Feb 27, 2026, 4:00 PM EST
13.03
+0.26 (2.04%)
After-hours: Feb 27, 2026, 6:56 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Discovering and Developing Engineered Antibody Therapeutics | 125.58M | 110.49M | 174.62M | 164.58M | 275.11M | | | | | |
Discovering and Developing Engineered Antibody Therapeutics Growth | 13.65% | -36.72% | 6.10% | -40.18% | 124.23% | | | | | |
| 125.58M | 110.49M | 174.62M | 164.58M | 275.11M | | | | | |
| 13.65% | -36.72% | 6.10% | -40.18% | 124.23% | | | | | |
Source: S&P Global Market Intelligence.
